IBOV 169,029.02 ▼ 1.16% IPC MEX 69,182.39 ▼ 0.76% MERVAL 2,848,945 — — USD/BRL5.40▲ 0.87% USD/MXN18.85▲ 1.12% USD/CLP990.22▲ 0.24% USD/COP3,165▲ 0.50% USD/PEN3.46▲ 0.28% USD/ARS1,538▼ 0.24% USD/UYU40.10▲ 3.30% USD/PYG5,838▲ 3.76% USD/BOB12.05▲ 4.53% USD/DOP60.36▲ 0.43% USD/CRC451.45▲ 2.55% USD/GTQ7.64▲ 3.31% USD/HNL26.87▲ 0.27% USD/NIO36.62▼ 0.02% USD/VES886.67▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 2.42% USD/TTD6.70▲ 2.01% EUR/BRL6.02▲ 1.20% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99% IBOV 169,029.02 ▼ 1.16% IPC MEX 69,182.39 ▼ 0.76% MERVAL 2,848,945 — — USD/BRL 5.34 ▼ 1.32% USD/MXN 18.69 ▲ 0.62% USD/CLP 983.47 ▼ 0.57% USD/COP 3,149 ▲ 3.06% USD/PEN 3.45 ▲ 0.17% USD/ARS 1,537 ▼ 0.28% USD/UYU 40.21 ▲ 3.57% USD/PYG 5,803 ▲ 3.78% USD/BOB 11.97 ▲ 4.93% USD/DOP 60.54 ▲ 1.83% USD/CRC 451.24 ▲ 2.13% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.87 ▲ 3.37% USD/NIO 36.62 ▲ 2.81% USD/VES 885.08 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.63% USD/TTD 6.71 ▲ 2.07% EUR/BRL 5.95 ▲ 7.53% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99%
since 2009
Thursday, October 29, 2026

Op-Ed Guest Opinions

Covid-19 Opinion: Yes, Big Pharma firms have huge profits – and they deserve them

By · October 22, 2021 · 3 min read
Covid-19 Opinion: Yes, Big Pharma firms have huge profits – and they deserve them
A photo illustration show the US Dollars in Buenos Aires, Argentina, on October 16, 2019. (Photo illustration by Carol Smiljan/NurPhoto)

Opinion, by Michael Royster

Rio de Janeiro, Brazil – (Opinion) Anti-vaccine arguments come in all sizes, shapes, and political colors. The latest species to infest (anti)social media posits both “Pfizer is earning immoral profits by selling its vaccine,” and its corollary “Pfizer is undermining governmental sovereignty.”

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

This writer strongly disagrees with the above-mentioned arguments, for a variety of reasons he will set out below.

[FULL DISCLOSURE: From 1974 to 1977, before he moved to Rio de Janeiro, the writer worked in New Jersey as a staff attorney in the international division of Schering-Plough Corporation, a medium-sized U.S. pharmaceutical firm.]

Preliminarily, let us admit that Pfizer/BioNTech, J&J, Moderna, and AstraZeneca (the 4 Western firms at the forefront of Covid-19 vaccine research) are indeed going to receive “windfall” profits in the billions of dollars for the next few years, as vaccinations against Covid-19 continue to be necessary.

However, let us recall that these firms are not alone – Chinese Sinovac, purveyor of CoronaVac in Brazil, is privately held; so is India’s Bharat Biotech, purveyor of Covaxin. Russia’s Gamaleya Institute is only technically government owned, as is China’s Sinopharm. All of them are reaping the benefits of creating and marketing vaccines. Even Cuba is desperately trying to develop vaccines it can export for hard currency, just as it does its doctors.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Bolsonaro's son lands in Miami despite passport order”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

So, why pick on Pfizer/BioNTech? Why is it perfectly acceptable for the governments of China, Russia, and Cuba, to make huge profits flogging their vaccines abroad, but not acceptable for privately held firms to do the same? Does anyone really believe governments will plough back all those vaccine profits into benefits for the local citizenry?

Moving on, we should remember that the very nature of the pharmaceutical business is highly risky. Big Pharma firms invest huge amounts of money trying to find new products, or improved versions of existing products – and the likelihood of doing so is minuscule. When they are successful, they seek not only to recover their costs, but also to generate enough profit to sustain future research. High risk/high gain.

Let us also briefly consider whether Big Pharma has compromised the sovereignty of the nations of the world, by insisting on contractual provisions for vaccines that broadly prevent governments suing them for anything other than manufacturing defects.

Vaccine manufacturers all know they are in competition with other capable manufacturers for government business – there are some 8 firms with sales in the millions around the world. Governments know this, and negotiate accordingly.  Brazil, for example, managed to obtain an unusually low price from Pfizer through negotiations.

Finally, let us consider the question of morals. If you are a capitalist, and believe that profits are not inherently evil, you should ask yourself the following question: Are profits in some businesses more deserved than in others?

For instance, how do you feel about the profits of the tobacco industry, responsible for killing millions? What about the coal industry, and the oil & gas behemoths, responsible for polluting the land, water and air essential to human life? What about agribusiness giants that destroy tropical forests? Etc. Etc. Etc.

In this writer’s opinion, if there is any business in the world that deserves to make outsize profits, it is the pharmaceutical business, whose purpose is to make lives safer by preventing, reducing, or even curing disease and death.

Particularly is this true in the case of vaccines, especially Covid-19 vaccines, which have demonstrably saved millions of lives that would otherwise have been lost, as occurred during the Spanish Flu pandemic a century ago.

Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.